Logo

Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19

Share this

Sanofi and Luminostics Collaborate to Develop Smartphone-Based Self-Testing Solution for COVID-19

Shots:

  • The collaboration leverages Luminostics’ technology and Sanofi’s global distribution network to ensure WW availability of the test- subject to relevant regulatory approvals. The focus of the collaboration is to develop a consumer-based test that can detect the COVID-19
  • Luminostics’ technology utilizes a consumer smartphone’s optics- controlled by an iOS/Android app paired with a reusable adapter- in combination with glow-in-the-dark nanochemistry and signal processing AI. The OTC self-testing solution is expected to be ready before the end of 2020
  • The rapid self-testing solution will eliminate the current need for HCPs or laboratory tests. The collaboration follows Sanofi’s collaboration with GSK for COVID-19 vaccine and initiation of clinical studies evaluating Kevzara and Plaquenil in patients suffering from COVID-19

Click here ­to­ read full press release/ article | Ref: Sanofi | Image: Usine Digitale

Related News: Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine

Sanofi and Regeneron to Initiate the Clinical Program Evaluating Kevzara (sarilumab) in Patients with Severe COVID-19

Sanofi and Regeneron Expand Clinical Program of Kevzara (sarilumab) for the Treatment of COVID-19 Outside the US


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions